1. Home
  2. CDP vs VERA Comparison

CDP vs VERA Comparison

Compare CDP & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo COPT Defense Properties of Beneficial Interest

CDP

COPT Defense Properties of Beneficial Interest

N/A

Current Price

$32.45

Market Cap

3.4B

Sector

Real Estate

ML Signal

N/A

Logo Vera Therapeutics Inc.

VERA

Vera Therapeutics Inc.

N/A

Current Price

$43.50

Market Cap

3.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CDP
VERA
Founded
1988
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
3.4B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
CDP
VERA
Price
$32.45
$43.50
Analyst Decision
Buy
Strong Buy
Analyst Count
7
11
Target Price
$33.00
$76.60
AVG Volume (30 Days)
1.3M
1.1M
Earning Date
02-05-2026
02-25-2026
Dividend Yield
3.81%
N/A
EPS Growth
10.15
N/A
EPS
1.35
N/A
Revenue
$763,923,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$4.21
N/A
P/E Ratio
$23.68
N/A
Revenue Growth
1.36
N/A
52 Week Low
$23.92
$18.53
52 Week High
$32.14
$56.05

Technical Indicators

Market Signals
Indicator
CDP
VERA
Relative Strength Index (RSI) 72.65 42.76
Support Level $30.93 $40.87
Resistance Level $30.75 $45.51
Average True Range (ATR) 0.63 2.18
MACD 0.16 -0.67
Stochastic Oscillator 83.39 22.10

Price Performance

Historical Comparison
CDP
VERA

About CDP COPT Defense Properties of Beneficial Interest

COPT Defense Properties is a fully-integrated and self-managed real estate investment trust (REIT) focused on owning, operating and developing properties in locations proximate to, or sometimes containing, key U.S. Government (USG) defense installations and missions. Its tenants include the USG and their defense contractors, who are engaged in priority national security activities, and who generally require mission-critical and high security property enhancements. Its properties include 195 operating properties totaling approximately 22.4 million square feet comprised of 16.5 million square feet in 164 office properties and 5.9 million square feet in 31 single-tenant data center shells.

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

Share on Social Networks: